References
- National Statistic Office. Republic of Korea annual report on the cause of death statistics. 2014. (http://kostat.go.kr)
- Kasper, Braunwald, Fauci, Hauser, longo, Jameson. Harrison's principles of internal medicine. 16th edition, Seoul, MIP. 546-59, 2006.
- 한용철. 임상호흡기학. 서울. 일조각. p137, 1995.
- Nelson, K.A., Walsh, D., Sheehan, F.A. The cancer anorexia-cachexia syndrome. J of Clinical Oncology 1994;12(1):213-25. https://doi.org/10.1200/JCO.1994.12.1.213
- 김은경, 양영희, 최수미. 입원한 암환자의 영양상태연구. 대한간호학회지 1999;29(2):271-80.
- 翁家武, 陳培丰. 癌症惡病質的中醫藥治療研究进展. 浙江 中西醫結合雜誌. 2009;19(2):123-5.
- Bruera E, Higginson I. Cachexia-Anorexia in cancer patients. New York, Oxford University Press. pp1-197, 1996.
- Giavassi R, Garofalo A, Bani MR, Abbte M, Grezzi P, Boraschi D, Mantovani A, Dejana E. Interlukin-1-induced augmentation of experimental metastasis from a human melanoma in node mice. Cancer Res. 1990;50:4771-5.
- Chirivi RG, Garofalo A, Padura IM, Mantovani A, Givazzi R. Interleukin-1 reciptor antagonists inhibits the augmentation of metastasis induced by IL-1 or LPS in human melanoma nude mouse system. Cancer REs. 1993;55:505.
- Tisdale MJ. Cancer cachexia. Anti-cancer Drugs. 1993;2:115-25.
- Watanabe S, Bruera E. Anorexia and cachexia, asthenia and lethargy. Hematology/Oncology Clinics of North America. 1996;10(1):189-206. https://doi.org/10.1016/S0889-8588(05)70334-8
- 嚴用和. 濟生方. 北京:人民衛生出版社. 1980. p. 117.
- 조수인, 조성희, 진천식. 歸脾湯및 歸脾湯加자하거 추출물 투여로 인한 난소적출 흰쥐의 체중 및 지질대사 변화. 대한 본초학회지. 2004;19:85-90.
- 김형철, 정대규. 歸脾湯, 加味溫膽湯및 歸脾溫膽湯의 抗Stress 效能比較硏究. 동의신경정신과학회지. 1993;4:99-119.
- 박선동, 박현준, 주왕석. 歸脾湯및 그구성약물군이 항산화효과에 미치는 영향. 대한본초학회지. 2001;16:11-27.
- 임동욱, 유동열, 김동희. 加味歸碑湯免 疫調節作用에 미치는 影響. 大韓韓方婦人科學會誌. 1999;12:253-80.
- Busta I, Xie HS, Kim MS. The use of Gui-Pi-Tang in small animals with immune-mediated blood disorders. J Vet Clin. 2009;26:181-4.
- 김성호, 이송은, 오헌, 양정아, 정치영, 장종식 등. 생쥐에서 歸脾湯및 구성단미 의 방사선 방호효과. 한국식품영양과학회지. 1999;28:698-704.
- 손지영, 최해윤, 김종대. 歸脾湯이 비소세포 폐암세포(NCI-H520) 이식 마우스에서 항암 및 면역 활성에 미치는 영향. 대한한방내과학회지. 2012;33(4):387-404.
- Shimizu Y, Kinoshita I, Kikuchi J, Yamazaki K, Nishimura M, Birrer MJ et al.. Growth inhibition of non-small cell lung cancer cells by AP-1 blockade using a cJun dominant-negative mutant. Br J Cancer. 2008;98:915-22. https://doi.org/10.1038/sj.bjc.6604267
- Cooks T, Schmidt M, Bittan H, Lazarov E, Arazi L, Kelson I et al. Local control of lung derived tumors by diffusing alpha-emitting atoms released from intratumoral wires loaded with radium-224. Int J Radiat Oncol Biol Phys. 2009;74:966-73. https://doi.org/10.1016/j.ijrobp.2009.02.063
- Institute of Laboratory Animal Resourcis (Commission on Life Science, National Research Council, USA). Guide for the care and use of laboratory animals. 7. Washington, D.C.:National Academic press. 1996. p. 1-118.
- Itoh H, Ito H, Amano H, Noda H. Inhibitory action of a (1-->6)-beta-D-glucan-protein complex (F III-2-b) isolated from Agaricus blazei Murill ("himematsutake") on Meth A fibrosarcoma-bearing mice and its antitumor mechanism. Jpn J Pharmacol. 1994;66:265-71. https://doi.org/10.1254/jjp.66.265
- Iizuka N, Miyamoto K, Hazama S, Yoshino S, Yoshimura K, Okita K et al. Anticachectic effects of Coptidis rhizoma, an anti-inflammatory herb, on esophageal cancer cells that produce interleukin 6. Cancer Lett. 2000;158:35-41. https://doi.org/10.1016/S0304-3835(00)00496-1
- Kim YC, Kwon YS, Oh IJ, Kim KS, Kim SY, Ryu JS. National survey of lung cancer in Korea, 2005. J. Lung Cancer. 2007;6:67-73. https://doi.org/10.6058/jlc.2007.6.2.67
- Tisdale MJ. Biology of cachexia. J Natl Cancer Inst. 1997;89:1763-73. https://doi.org/10.1093/jnci/89.23.1763
- Inui A. Cancer anorexia-cachexia syndrome: are neuropeptides the key?. Cancer Res. 1999;59:4493-501.
- Oka M, Yamamoto K, Takahashi M, Hakozaki M, Abe T, Iizuka N at al. Relationship between serum levels of interleukin 6, various disease parameters and malnutrition inpatients with esophageal squamous cell carcinoma. Cancer Res. 1996;56:2776-80.
- Kim EK, Yang YH, Choi SM. Nutritional Status of Cancer Patients upon Admission. J Korean Nurses Association. 1999;29(2):271-80.
- 송광규, 박미연, 최해윤, 김종대. 암성 악액질의 한약치료에 대한 고찰(2000- 2009년까지 중의논문을 중심으로). 한국한의학연구원논문집. 2010;16(2):181-91.
- Perboni S, Inui A. Anorexia in cancer: role of feeding-regulatory peptides. Phil Trans R Soc B. 2006;361:1281-9. https://doi.org/10.1098/rstb.2006.1863
- Suto G, Kiraly A, Tache Y. IL-1b inhibits gastric emptying in rats: mediation through prostaglandin and corticotropin-releasing factor. Gastroenterology 1994;106:1568-75. https://doi.org/10.1016/0016-5085(94)90412-X
- Tisdale MJ. Metabolic abnormalities in cachexia and anorexia. Nutrition 2000;16:1013-4. https://doi.org/10.1016/S0899-9007(00)00409-3
- 方葯中, 鄧鐵淺, 李克光, 陳可冀, 金壽山. 黃星垣등. 실용중의내과학. 상해:상해과학기술출판사. 1986. p. 621-36.
- 문구, 정병학, 김병주. 암동서의결합치료(I). 익산:원광대학교출판국. 1999. p.253-303, 383-460.
- 국윤범, 김상찬, 박선동, 박성규, 서부일, 서영배 등. 方劑學. 서울:영림사. 2008. p. 290-2.
- Hanada M, Noguchi T, Yamaoka T. Amrubicin, a novel 9-aminoanthracycline, enhances the antitumor activity of chemotherapeutic agents against human cancer cells in vitro and in vivo. Cancer Sci. 2007;98:447-54. https://doi.org/10.1111/j.1349-7006.2007.00404.x
- Okabe T, Okamoto I, Tsukioka S, Uchida J, Hatashita E, Yamada Y et al. Addition of S-1 to the epidermal growth factor receptor inhibitor gefitinib overcomes gefitinib resistance in non-small cell lung cancer cell lines with MET amplification. Clin Cancer Res. 2009;15:907-13. https://doi.org/10.1158/1078-0432.CCR-08-2251
- Natsume T, Watanabe J, Horiuchi T, Kobayashi M. Combination effect of TZT-1027 (Soblidotin) with other anticancer drugs. Anticancer Res. 2006;26:1145-51.
- Foster PA. Steroid metabolism in breast cancer. Minerva Endocrinol. 2008;33:27-37.
- Clark JC, Dass CR, Choong PF. Development of chondrosarcoma animal models for assessment of adjuvant therapy. ANZ J Surg. 2009;79:327-36. https://doi.org/10.1111/j.1445-2197.2009.04884.x
- Kim YC, Kwon YS, Oh IJ, Kim KS, Kim SY et al. National survey of lung cancer in Korea, 2005. J Lung Cancer. 2007;6:67-73. https://doi.org/10.6058/jlc.2007.6.2.67